Search Results for "Treatment Of Neurofibroma In India"

11:11 EDT 18th April 2015 | BioPortfolio

Matching Channels


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to:    

Specific treatment

Treatment of Anemia

Matching News

Rheumatology in India—quo vadis?

The treatment of rheumatic diseases in India is beset with several problems, such as a high patient load and grossly inadequate number of trained rheumatology specialists. In this Perspectives article...

'Cancer care in India needs urgent attention'

Biospectrum A Cancer conclave was held at Aster Medcity, Kochi, India to analyze the demographics of cancer care in Ind...

Hetero Received Generic Sofosbuvir (Gilead's Sovaldi) Approval From Drug Controller General of India (DCGI)

HYDERABAD, INDIA -- (Marketwired) -- 03/12/15 -- Hetero, a leading pharmaceutical company based in Hyderabad, India, today announced that it has received approval for generic Sofosbuvir Tablets, 400...

'Responsibly' priced Invokana debuts in India

The daily cost of therapy with Invokana in India is INR51 ($0.8), generally comparable with the newer treatment options available in the country and a fraction of the product's US cost, reported in so...

Mylan and Gilead partner for Sovaldi and Harvoni in India

Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India. ...

Canada, India fund 5 innovations to improve health in India, with focus on mothers and children

(Terry Collins Assoc) Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship...

BioAsia 2015: Fixes To India’s Medicines Access Issue

Access to medicines is a hot button topic in India. The government has spoken on interventions like establishing low cost generic drug stores, while the industry is toying with financing models to imp...

Medics in Rural India Unaware of Correct Treatment for Childhood Infections

A vast majority of healthcare providers in Bihar province of northern India interviewed for a recent study were unaware of the appropriate treatments for diarrhea and pneumonia, the biggest contributo...

Matching PubMed Articles

A Rare Solitary Neurofibroma of the Frontal Sinus.

Neurofibromas are common peripheral nerve sheath tumors related to Schwann cell's proliferation and are usually associated with neurofibromatosis type 1. Although solitary neurofibroma that occurs in ...

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India.

Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-ea...

Extensive Plexiform Neurofibroma in a Premature Neonate.

We describe a premature neonate with an extensive plexiform neurofibroma. Prenatal ultrasound at 32 weeks of gestation was normal. Postnatal examination was significant for a palpable left neck mass. ...

A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE).

There is limited available information for treatment of acute coronary syndrome (ACS) with respect to outcomes, therapeutic agents and treatment practices. Our retrospective registry study collected a...

Solitary Epibulbar Neurofibroma in Older Adult Patients.

To report a solitary epibulbar neurofibroma in 2 elderly patients without systemic neurofibromatosis.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement